Case Reports
The Koebner Phenomenon in Bullous Pemphigoid
April 2024 | Volume 23 | Issue 4 | Case Reports | e100 | Copyright © April 2024
Cutaneous Squamous Cell Carcinoma In Situ on a Fingernail Treated With HPV Vaccine
April 2024 | Volume 23 | Issue 4 | Case Reports | 275 | Copyright © April 2024
Mitogen-Activated Protein Kinase Inhibitor-Induced Inflammatory Alopecia in Woman With Ovarian Cancer
April 2024 | Volume 23 | Issue 4 | Case Reports | e102 | Copyright © April 2024
Inflammatory alopecia is an increasingly reported side effect of targeted cancer therapies. Here we report one case of inflammatory alopecia secondary to mitogen-activated protein kinase kinase (...
Read MorePemphigus Vulgaris Successfully Treated With Bromocriptine
March 2024 | Volume 23 | Issue 3 | Case Reports | e83 | Copyright © March 2024
Pemphigus vulgaris (PV) is an autoimmune blistering skin condition primarily treated with immunosuppressive agents. We describe a case of PV successfully treated with nonconventional treatment, b...
Read MoreNovel Clinical Applications of Topical Ruxolitinib: A Case Series
March 2024 | Volume 23 | Issue 3 | Case Reports | 188 | Copyright © March 2024
Topical ruxolitinib, a potent Janus kinase (JAK) inhibitor, has shown significant efficacy in treating inflammatory skin conditions. While its use has already been established in atopic dermatiti...
Read MoreUrticaria Pigmentosa Without Pruritus
March 2024 | Volume 23 | Issue 3 | Case Reports | e81 | Copyright © March 2024
Mastocytosis is a group of disorders characterized by the pathologic accumulation of mast cells in various tissues. One example of mastocytosis is urticaria pigmentosa, which presents with mastoc...
Read MoreFirst Use of Combination Oral Deucravacitinib With Tapinarof Cream for Treatment of Severe Plaque Psoriasis
March 2024 | Volume 23 | Issue 3 | Case Reports | 192 | Copyright © March 2024
Plaque psoriasis is a chronic, immune-mediated, cutaneous, and systemic inflammatory dermatosis. Its pathogenesis involves the dysregulation of the interleukin (IL)-23/IL-17 signaling pathway. Th...
Read MorePsoriasis and Palmoplantar Pustulosis Following Pembrolizumab Therapy Successfully Treated With Topical Tapinarof Cream 1%
February 2024 | Volume 23 | Issue 2 | Case Reports | 103 | Copyright © February 2024
Atypical Dyschromia in Skin of Color
February 2024 | Volume 23 | Issue 2 | Case Reports | 100 | Copyright © February 2024
Dyschromia is a concern for many patients, especially persons of color. Postinflammatory hypopigmentation and depigmentation can affect all skin types; however, it is more apparent in those with ...
Read MoreAtopic Dermatitis as a Paradoxical Reaction to Secukinumab in a Patient With Plaque Psoriasis
February 2024 | Volume 23 | Issue 2 | Case Reports | 97 | Copyright © February 2024
Paradoxical reactions to biologic agents used in the treatment of psoriasis are rare but have been reported with tumor necrosis factor (TNF) blockers and, more recently, with interleukin (IL)-17A...
Read MoreSarecycline as a Potential Treatment for Steroid-Induced Rosacea/Perioral Dermatitis: A Case Report
February 2024 | Volume 23 | Issue 2 | Case Reports | e55 | Copyright © February 2024
Neoadjuvant PD-1 Inhibitors: A Tale of Two Cases
February 2024 | Volume 23 | Issue 2 | Case Reports | e57 | Copyright © February 2024
Treatment responses for locally advanced cutaneous squamous cell carcinoma (cSCC) and Merkel cell carcinoma (MCC) are often short lived and are marred with recurrences. The introduction of adjuva...
Read MoreA Case Series of TNF Inhibitor-Induced Psoriasis Successfully Treated With Upadacitinib
February 2024 | Volume 23 | Issue 2 | Case Reports | e60 | Copyright © February 2024
Tumor necrosis factor-alpha inhibitors (TNF-i) are commonly used to treat immune-mediated diseases such as psoriasis, psoriatic arthritis (PsA), inflammatory bowel disease (IBD), spondyloarthriti...
Read MorePost-Hyaluronic Acid Filler Reaction Treated With Abrocitinib: A Case Report
January 2024 | Volume 23 | Issue 1 | Case Reports | 1355 | Copyright © January 2024
Post-hyaluronic acid filler nodules are uncommon, unpredictable complications that present a challenge to clinical therapy. We report a case of a female in her fifties who developed edema and nod...
Read MoreIntralesional Sodium Thiosulfate as Adjuvant Therapy in Severe Calciphylaxis
December 2023 | Volume 22 | Issue 12 | Case Reports | e28 | Copyright © December 2023
Calciphylaxis is a rare disease characterized by calcification of the middle layer of small arteries and arterioles, causing secondary cuta-neous ischemia. The diagnosis is clinical but may be co...
Read MoreSuccessful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional Dupilumab
December 2023 | Volume 22 | Issue 12 | Case Reports | 1220 | Copyright © December 2023
Keloids and hypertrophic scars negatively impact the quality of life for millions of people in the world. Unfortunately, though many thera-peutic approaches are used to treat scars, they are ofte...
Read MoreMultiple Halo Nevi Induced by Intense Sun Exposure
December 2023 | Volume 22 | Issue 12 | Case Reports | e31 | Copyright © December 2023
We present the case of a 38-year-old male who reported to our practice with multiple newly developed halos around 26 existing nevi on his trunk. The halo nevi developed after the patient, who liv...
Read MoreA Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma
December 2023 | Volume 22 | Issue 12 | Case Reports | 1223 | Copyright © December 2023
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, and extranodal involvement is seen in approximately 40% of cases. However, cases involving the skin and musc...
Read MoreCheckpoint Inhibitor-Induced Neurotoxicity in a Case of Metastatic Melanoma
December 2023 | Volume 22 | Issue 12 | Case Reports | e25 | Copyright © December 2023
Checkpoint inhibitors (CPIs) are increasingly being used in the treatment of malignant melanoma. While showing promise in metastatic melanoma treatment, CPIs are associated with immune-related ad...
Read MoreManagement of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review
November 2023 | Volume 22 | Issue 11 | Case Reports | e24 | Copyright © November 2023
Introduction: Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare and dangerous dermatologic emergency. It can have different presentations, especially in pat...
Read More